NYSEARCA:XPH SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News $48.05 +0.41 (+0.86%) (As of 11/8/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings About SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get XPH alerts:Sign Up Key Stats Today's Range$47.31▼$48.2650-Day Range$43.25▼$48.0552-Week Range$34.67▼$48.26Volume32,407 shsAverage Volume41,030 shsMarket Capitalization$233.04 millionAssets Under Management$168.40 millionDividend Yield1.39%Net Expense Ratio0.35%Aggregate RatingModerate Buy ETF OverviewSPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Read More… Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov SPDR S&P Pharmaceuticals ETF ExpensesTypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.35%0.57%0.55%0.51%0.52%Other Expenses0.00%0.30%0.49%0.58%0.53%Total Expense0.35%0.70%0.71%0.73%0.71%Fee Waiver0.00%-0.45%-0.52%-0.67%-0.57%Net Expense0.35%0.61%0.61%0.58%0.59% Receive XPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address XPH ETF News HeadlinesShuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per shareOctober 30, 2024 | markets.businessinsider.comBalanced Outlook on Apellis Pharmaceuticals: Promising Empaveli Data Amid Syfovre Growth ChallengesOctober 28, 2024 | markets.businessinsider.comTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a half years… Make no mistake, this division will definitely change YOUR financial future, for better or worse… That is why I’m sharing my post-election analysis of how this hidden division will impact your financial future…November 10, 2024 | Banyan Hill Publishing (Ad)Bristol Myers Squibb: A High-Yield Bargain With Growth On The HorizonOctober 6, 2024 | seekingalpha.comBottom-up default shifts significantly lower for telecoms, pharma; higher for techAugust 30, 2024 | msn.comSPDR S&P Pharmaceuticals ETF (XPH)March 30, 2024 | finance.yahoo.comSee More Headlines XPH ETF - Frequently Asked Questions How have XPH shares performed this year? SPDR S&P Pharmaceuticals ETF's stock was trading at $41.62 at the beginning of 2024. Since then, XPH stock has increased by 15.4% and is now trading at $48.05. View the best growth stocks for 2024 here. Who are SPDR S&P Pharmaceuticals ETF's major shareholders? SPDR S&P Pharmaceuticals ETF's top institutional shareholders include First Citizens Bank & Trust Co. (1.49%), MAI Capital Management (0.79%), PNC Financial Services Group Inc. (0.49%) and AlphaMark Advisors LLC (0.13%). How do I buy shares of SPDR S&P Pharmaceuticals ETF? Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META). Fund Details IssuerSSgA Fund NameSPDR S&P Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:XPH Inception Date6/19/2006 Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson Webwww.spdrs.com Phone+1-617-6644738Fund Focus Asset ClassEquity BenchmarkS&P Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings50 Fund Statistics Assets Under Management$168.40 million Average Daily Volume$80,078.80 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorSSgA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerCitadel Options OptionableN/A Short Interest413,000 shs Miscellaneous Outstanding Shares4,850,000Beta0.87 Creation Unit50,000 Creation Fee$250.00 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Top 10 XPH HoldingsCorcept Therapeutics (NASDAQ:CORT)Holding Weight: 4.20%Longboard Pharmaceuticals (NASDAQ:LBPH)Holding Weight: 4.02%Bristol-Myers Squibb (NYSE:BMY)Holding Weight: 3.67%Edgewise Therapeutics (NASDAQ:EWTX)Holding Weight: 3.64%Jazz Pharmaceuticals (NASDAQ:JAZZ)Holding Weight: 3.58%Intra-Cellular Therapies (NASDAQ:ITCI)Holding Weight: 3.54%Royalty Pharma (NASDAQ:RPRX)Holding Weight: 3.44%Catalent (NYSE:CTLT)Holding Weight: 3.42%Viatris (NASDAQ:VTRS)Holding Weight: 3.41%Pfizer (NYSE:PFE)Holding Weight: 3.39%Full Holdings DetailsXPH Sector ExposureXPH Industry Exposure This page (NYSEARCA:XPH) was last updated on 11/10/2024 by MarketBeat.com Staff From Our PartnersTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis “IRS Loophole” Allows You to Do WHAT?Little-Known IRS Loophole Beats Inflation 4x Over New guide reveals how to take advantage of this federally...Gold Safe Exchange | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI Got FiredStarting off with a few hundred bucks, it wasn't long before I started generating $1,000 a day. Then $10,00...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.